Equities

Utah Medical Products Inc

Utah Medical Products Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)87.50
  • Today's Change0.67 / 0.77%
  • Shares traded1.88k
  • 1 Year change-9.94%
  • Beta0.2802
Data delayed at least 15 minutes, as of Sep 27 2022 15:50 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Utah Medical Products, Inc. (UTMD) is engaged in the business of producing medical devices that are predominantly differentiated by safety and improved patient outcomes. UTMD’s products include Blood Monitoring, which includes Deltran Disposable Blood Pressure Transducers, Deltran Plus Arterial Blood Sampling Systems, and Deltran Accessories; Electrosurgery, which includes Epitome Electrosurgical Scalpels, OptiMicro Ultra-Fine Tip Electrosurgical Needles, Finesse+ Electrosurgical Generators, Filtresse Surgical Smoke Evacuation Systems and Finesse+ Accessories; Labor and Delivery, which includes AROM-Cot, BT-Cath, CVX-Ripe, Intran, Muc-X and Cordguard; Neonatal Intensive Care, which includes Hemo-Nate, Thora-Cath, Nutri-Cath, Nutri-Lok, Myelo-Nate, Disposa-Hood, Neonatal Deltran, Pala-Nate, PICC-Nate, Dialy-Nate, Umbili-Cath and Uri-Cath; Urological Care, which includes the Liberty, Supra-Foley, and Pathfinder Plus; Womens Pelvic Health, and original equipment manufacturer/Capabilities.

  • Revenue in USD (TTM)51.24m
  • Net income in USD15.98m
  • Incorporated1978
  • Employees178.00
  • Location
    Utah Medical Products Inc7043 S 300 WestMIDVALE 84047United StatesUSA
  • Phone+1 (801) 566-1200
  • Fax+1 (801) 566-7305
  • Websitehttp://www.utahmed.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Beyond Air Inc0.00-47.37m234.02m70.00--3.54-----1.69-1.690.002.210.00----0.00-71.98---84.30----------8.34-35.410.0114---100.00---88.75------
Clearpoint Neuro Inc19.09m-16.39m240.47m80.00--5.61--12.60-0.718-0.7180.83451.750.2881.226.63238,587.50-24.73-40.19-26.72-48.6467.4867.53-85.88-72.749.12-26.470.1872--27.0523.17-112.47--10.71--
Semler Scientific Inc54.38m13.09m248.97m124.0022.664.8418.154.581.621.626.717.571.054.9010.56438,524.2025.2754.2928.7871.8689.9288.3824.0731.467.15--0.00--37.3648.1322.95--0.2688--
ZimVie Inc-100.00bn-100.00bn263.97m2.70k--0.3452----------29.31------------------------1.41--0.4196--11.20--46.79------
Sight Sciences Inc59.90m-80.21m297.44m212.00--1.55--4.97-1.75-1.751.314.010.40852.606.90282,528.30-54.70---60.08--83.68---133.92--16.38-17.120.1468--77.12---81.48------
Edap Tms SA (ADR)48.57m2.44m298.92m227.00134.085.51--6.150.06170.06171.331.500.64863.483.74213,963.303.25-0.19234.20-0.288143.1143.555.01-0.24863.18--0.1075--5.774.35141.08-28.860.5449--
Agape ATP Corp1.22m-2.26m302.56m36.00--119.79--248.60-0.012-0.0120.00510.03350.25950.8768--33,807.22-48.00---59.36--69.85---185.00--2.52-3.740.00---70.55---811.51------
MiMedx Group Inc256.26m-27.87m307.88m811.00------1.20-0.2487-0.24872.300.69441.443.636.84315,980.30-12.07-7.76-16.02-12.1583.3686.74-8.38-4.203.17-2.760.38--4.183.1380.29---13.21--
Utah Medical Products, Inc.51.24m15.98m314.75m178.0019.902.9313.596.144.364.3613.9929.650.43992.8810.74287,848.3013.7213.7714.2614.3662.2062.5731.1831.6916.13--0.0038.0016.304.5333.694.05-30.081.84
Zynex Inc.142.99m19.72m332.60m774.0017.334.8814.742.330.49970.49973.591.781.412.306.20184,746.8019.4126.6522.4733.7180.2879.7113.7916.902.9892.510.1652--62.6357.8188.48201.1921.93--
Vuzix Corp11.84m-45.49m361.55m106.00--2.75--30.53-0.7145-0.71450.18612.060.07751.028.55111,734.10-29.77-55.33-30.87-60.6915.682.36-384.05-280.3913.50-856.220.00--13.6743.98-101.80--17.29--
Iradimed Corp47.81m12.20m369.67m110.0030.485.6126.697.730.96520.96523.785.250.6322.287.80434,658.5016.129.3917.5710.2977.7576.1425.5116.1910.37--0.000.0031.835.171,538.925.27-13.42--
Orthofix Medical Inc461.98m-36.95m391.07m1.09k--1.14--0.8465-1.86-1.8623.2017.100.95881.366.14425,004.60-7.67-1.53-9.23-1.9073.7077.14-8.00-1.601.953.420.0558--14.252.54-1,624.79--2.60--
SmileDirectClub Inc541.41m-99.54m397.76m3.20k--2.82--0.7347-0.8318-0.83184.520.36230.65194.232.84169,190.90-38.95---33.66--70.28---59.74--2.26-29.541.48---2.92---30.72------
Akoya Biosciences Inc64.42m-62.89m402.80m149.00--4.42--6.25-1.68-1.681.722.410.32992.566.92201,949.80-32.35---37.31--60.72---98.08--3.16-18.530.3256--29.39---103.89------
SurModics, Inc.97.93m-12.84m405.86m389.00--3.24--4.14-0.9226-0.92267.058.940.55512.196.01251,758.40-7.281.77-8.392.0380.7084.37-13.113.081.67-53.050.0740.0010.838.06277.29-15.76-5.18--
Data as of Sep 27 2022. Currency figures normalised to Utah Medical Products Inc's reporting currency: US Dollar USD

Institutional shareholders

50.72%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 30 Jun 2022381.31k10.46%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 2022364.51k10.00%
Renaissance Technologies LLCas of 30 Jun 2022227.37k6.24%
BlackRock Fund Advisorsas of 30 Jun 2022182.55k5.01%
The Vanguard Group, Inc.as of 30 Jun 2022161.11k4.42%
Dimensional Fund Advisors LPas of 30 Jun 2022152.95k4.20%
Rice, Hall, James & Associates LLCas of 30 Jun 2022118.89k3.26%
JPMorgan Investment Management, Inc.as of 30 Jun 202299.17k2.72%
Healthinvest Partners ABas of 30 Jun 202286.00k2.36%
Ranger Investment Management LPas of 30 Jun 202274.88k2.05%
More ▼
Data from 30 Jun 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.